GK921
GK921 is a transglutaminase 2 (TGase 2) inhibitor. GK921 showed cytotoxicity to RCC (average GI50 in eight RCC cell lines: 0.905 μM) . A single treatment with GK921 almost completely reduced tumor growth by stabilizing p53 in the ACHN and CAKI-1 preclinical xenograft tumor models. TGase 2 inhibitor GK921 abrogates RCC growth in xenograft tumor models, suggesting the possibility of a new therapeutic approach to RCC.
Product Specifications
CAS Number
1025015-40-0
Product Name Alternative
GK921 | GK-921 | GK 921
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 30 mg/mL 87.11 mM
Smiles
C1CCN (C1) CCOc1c (nc2c (n1) cccn2) C#Cc1ccccc1
Molecular Formula
C21H20N4O
Molecular Weight
344.42
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3- (phenylethynyl) -2- (2- (pyrrolidin-1-yl) ethoxy) pyrido[2,3-b]pyrazine
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6311906-01 0.2 mL
K0776, ID (UFL1, KIAA0776, NLBP, E3 UFM1-protein ligase 1, LZAP-binding protein) (AP)
Sign In for Pricing
View Details MBS6311906-02 5x 0.2 mL
K0776, ID (UFL1, KIAA0776, NLBP, E3 UFM1-protein ligase 1, LZAP-binding protein) (AP)
Sign In for Pricing
View Details 